You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Evaluation of Dextenza in Patients With Ocular GVHD and Effects on Ocular Surface Disease Outcomes - 2021
Withdrawn
  • Graft Vs Host Disease
  • DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use
  • Regular dissolvable intracanalicular plug
  • Boston, Massachusetts
    Mass Eye and Ear
2021-12-14
Dec 14, 2021
F
Chronic GVHD Response Measures Validation
Active, not recruiting
  • Graft vs Host Disease
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center
    2022-02-28
    Feb 28, 2022
    M
    Evaluation of the Impact of Reduced Immunosuppression
    Enrolling by invitation
    • Graft Vs Host Disease
    • Dallas, Texas
      Methodist Dallas Medical Center
    2022-02-21
    Feb 21, 2022
    N
    Dexamethasone to Prevent Oral Chronic Graft-versus-Host Disease - 2021
    Completed
    Has Results
    • Graft vs Host Disease
    • Topical Dexamethasone
    • Placebo
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2022-01-20
    Jan 20, 2022
    U
    18-FLT PET/MR Imaging to Predict Graft Failure and GVHD in Bone Marrow Transplant Patients
    Active, not recruiting
    • Graft Vs Host Disease
    • Fluorothymidine (FLT)
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center
    2022-03-21
    Mar 21, 2022
    U
    Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
    Recruiting
    • Hematologic Diseases
    • +11 more
    • Ann Arbor, Michigan
      University of Michigan Health System
    2021-12-02
    Dec 2, 2021
    F
    Donor Regulatory T-cells for cGVHD in Patients Who do Not Obtain Complete Remission With Ruxolitinib
    Not yet recruiting
    • Chronic Graft vs Host Disease
    • Regulatory T-cell enriched infusion
    • (no location specified)
    2021-10-15
    Oct 15, 2021
    W
    Baricitinib for the Prophylaxis of Graft-Versus-Host Disease After Peripheral Blood Hematopoietic Cell Transplantation
    Recruiting
    • Graft-versus-host-disease
    • Graft Vs Host Disease
    • Saint Louis, Missouri
      Washington University School of Medicine
    2022-03-04
    Mar 4, 2022
    S
    Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate/Severe Chronic Graft-versus-host Disease
    Recruiting
    • Graft Vs Host Disease
    • Umbilical Cord Mesenchymal Stem Cell Therapy
    • Shenzhen, Guangdong, China
      Li Yu
    2021-12-04
    Dec 4, 2021
    N
    Natural History Study of Clinical and Biological Factors Determining Outcomes in Chronic Graft-Versus-Host Disease
    Recruiting
    • Chronic Graft vs Host Disease
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2022-04-07
      Apr 7, 2022
      C
      Detection of Graft Versus Host Disease With [18F]F-AraG
      Recruiting
      • Graft Versus Host Disease
      • Stanford, California
        Stanford Hospital
      2022-03-07
      Mar 7, 2022
      A
      ASC930 in Patients With Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)
      Not yet recruiting
      • Acute-graft-versus-host Disease
      • ASC930
      • (no location specified)
      2021-11-16
      Nov 16, 2021
      M
      Multidisciplinary Intervention In Chronic GVHD
      Recruiting
      • Stem Cell Transplant Complications
      • +3 more
      • Horizon Program
      • Usual Care
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      2021-08-31
      Aug 31, 2021
      W
      Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation
      Recruiting
      • Graft Vs Host Disease
      • Graft-versus-host-disease
      • Saint Louis, Missouri
        Washington University School of Medicine
      2021-10-28
      Oct 28, 2021
      B
      Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
      Enrolling by invitation
      • Graft Vs Host Disease
      • Duarte, California
      • +7 more
      2022-03-30
      Mar 30, 2022
      H
      PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis
      Recruiting
      • Graft Versus Host Disease
      • Detroit, Michigan
        Henry Ford Hospital
      2021-12-23
      Dec 23, 2021
      S
      Neihulizumab for Standard-Risk Acute Graft Versus Host Disease (GVHD)
      Recruiting
      • Graft-versus-host Disease
      • Neihulizumab, 3 mg/kg
      • +3 more
      • Milwaukee, Wisconsin
        Froedtert Hospital and the Medical College of Wisconsin
      2021-09-09
      Sep 9, 2021
      C
      Study of Ruxolitinib for Acute and Chronic Graft Versus Host Disease
      Recruiting
      • Acute-graft-versus-host Disease
      • +2 more
      • Cincinnati, Ohio
        Cincinnati Children's Hospital Medical Center
      2022-03-31
      Mar 31, 2022
      N
      Study of Baricitinib, a JAK1/2 Inhibitor, in Chronic Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
      Active, not recruiting
      • Chronic Graft vs Host Disease
      • Chronic Graft-Versus-Host Disease
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2022-04-07
      Apr 7, 2022
      T
      oGVHD After Bone Marrow Transplantation: a Territory-wide Cohort
      Recruiting
      • Graft Vs Host Disease
      • +2 more
        • Hong Kong, Hong Kong
          Department of Ophthalmology, LKS Faculty of Medicine, The Univer
        2021-12-09
        Dec 9, 2021
        N
        Topical Ruxolitinib for Cutaneous Chronic Graft Versus Host Disease (cGVHD) - 2022
        Completed
        • Graft Versus Host Disease
        • +2 more
        • Ruxolitinib 1.5% cream
        • vehicle cream
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        2022-03-30
        Mar 30, 2022
        T
        Evaluation of Tangible Boost for Patients With Stevens Johnson Syndrome, Sjogren's Syndrome, and Graft Vs Host Disease
        Recruiting
        • Stevens-Johnson Syndrome
        • +3 more
        • Tangible Boost
        • Placebo
        • Needham, Massachusetts
          Boston Sight
        2021-03-29
        Mar 29, 2021
        D
        Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
        Not yet recruiting
        • Graft Vs Host Disease
        • +2 more
        • Exercise
        • Attention control
        • Boston, Massachusetts
        • +1 more
        2022-02-01
        Feb 1, 2022
        H
        A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression
        Active, not recruiting
        • Graft Vs Host Disease
        • GVHD
        • Tampa, Florida
        • +1 more
        2022-02-11
        Feb 11, 2022
        N
        Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
        Recruiting
        • Graft-versus-leukemia
        • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          2022-04-07
          Apr 7, 2022